DELRAY BEACH, Fla., Sept. 2, 2025 /PRNewswire/ -- The global European Infection Control Market, valued at US$14.14 billion in 2024, stood at US$14.99 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$20.58 billion by the end of the period. The market for infection control is growing due to several factors, including the increasing prevalence of healthcare-associated infections (HAIs), a rise in the number of surgeries, advancements in reprocessing technology, an increased focus on sterilization and disinfection in the food industry, improvements in sterilization equipment technology, and a growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11051524
Browse in-depth TOC on "European Infection Control Market"
468 - Tables
47 - Figures
476 - Pages
By sterilization products & services, the sterilization products & services segment is further classified into sterilization equipment, contract sterilization services, and consumables & accessories. The sterilization equipment segment accounted for the largest share of the European infection control market in 2024. The large share of this segment can be attributed to various factors, such as the growing number of surgical procedures, diagnostic interventions, strict standards set by regulatory agencies, advancements in sterilization technologies, and increasing healthcare-associated infections (HAIs).
By end user, the infection control market is segmented into hospitals & clinics, medical device companies, pharmaceutical companies, the life sciences industry, the food industry, and other end users. The hospitals & clinics segment accounted for the largest share of the infection control market in 2024. The overall demand for infection control in hospitals is primarily driven by the rise in hospital-acquired infections (HAIs), the expanding establishment of hospitals & clinics, and the increasing incidence of chronic & infectious diseases.
By geography, The European infection control market is segmented into 13 countries: Germany, the UK, France, Italy, Spain, Switzerland, Poland, Austria, Romania, the Czech Republic, Slovakia, Portugal, and the rest of Europe. In 2024, Germany accounted for the largest share of the European infection control market due to several reinforcing factors, such as Germany's advanced healthcare infrastructure and the high volumes of surgeries & hospital admissions.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=11051524
Prominent players in the European infection control market include STERIS plc. (US), Getinge AB (Sweden), Ecolab, Inc. (US), Solventum Corporation (US), Advanced Sterilization Products (US), Kimberly-Clark Corporation (US), B. Braun Group (Germany), Olympus Corporation (Japan), Paul Hartmann AG (Germany), Reckitt Benckiser (UK), Cardinal Health (US), Miele Group (Germany), MMM Group (Germany), MATACHANA GROUP (Spain), and Medline Industries, LP (US) among others.
STERIS (US):
STERIS continues strengthening its position as a powerhouse in the infection control market through strategic acquisitions and expanded service capabilities. In August 2023, the company finalized a USD 540? million acquisitions of surgical instrumentation and sterilization container assets from Becton, Dickinson and Company, including recognized brands such as V.Mueller, Snowden-Pencer, and Genesis, which added approximately USD 170? million in annual revenue and broadened STERIS's healthcare segment offerings in sterile processing and surgical tools.
Reckitt Benckiser (UK)
Reckitt Benckiser is a key leader in the European Infection Control space, accounting for the second-largest share of the market. Reckitt Benckiser has sharpened its strategic focus on infection control across Europe by doubling its core Power Brands Dettol and Lysol while streamlining its broader brand portfolio to concentrate on high-growth, high-margin categories. Notably, in November 2022, Reckitt launched a co-branded professional hygiene product range in partnership with Essity, integrating Dettol and Sagrotan into Essity's Tork distribution network across the UK, Germany, Ireland, and Austria. This initiative was designed specifically for institutional settings such as healthcare facilities and represented Reckitt's deliberate expansion into professional-use infection control solutions.
Paul Hartmann AG (germany)
Paul Hartmann AG has reinforced its leadership in European infection prevention by expanding its Mission: Infection Prevention initiative launched in 2020 in collaboration with clinical partners and the WHO's Patient Safety Day, focusing on common HAIs and offering consultancy, digital hygiene monitoring, and tailored disinfection plans through its BODE Science Center.
For more information, Inquire Now!
Related Reports:
Infection Control Market
Top 10 Medical Device Technologies Market
Sterilization Equipment Market
Surface Disinfectant Market
Infectious Disease Diagnostics Market
Get access to the latest updates on European Infection Control Companies and European Infection Control Market Size
About MarketsandMarkets:
MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/european-infection-control-market-worth-us20-58-billion-by-2030-with-6-6-cagr--marketsandmarkets-302543574.html
